Statens Serum Institut

Statens Serum Institut, established in 1902, is a prominent public institution operating under the Danish Ministry of Health. Its core mission is to reinforce public health through advanced disease control strategies and comprehensive research initiatives. As an integral component of Danish and international health services, the institute plays a critical role in ensuring preparedness against infectious diseases and biological threats, alongside managing the control of congenital disorders. Its founding year and mission are key identifiers of its long-standing commitment to public health.

With a workforce ranging from 500 - 1,000 employees, Statens Serum Institut stands as one of Denmark's largest research institutes. The organization's extensive work encompasses the development and provision of vital products such as vaccines, sera, and diagnostic tests, contributing significantly to public health infrastructure. Its operational scope extends beyond national borders, supporting global health initiatives. Meet Statens Serum Institut's team to understand the expertise driving these critical public health efforts.

The institute's research and disease monitoring capabilities are crucial for identifying and mitigating health risks. Statens Serum Institut generates substantial revenue, reported at $230.8M, underscoring its significant operational scale and impact. Its commitment to scientific advancement and public health security solidifies its position as a key player in global health preparedness and disease management.